Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AlloVir (ALVR)
NASDAQ:ALVR
ALVR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.96 - $24.15
Previous CloseN/A
Volume83.88K
Average Volume (3M)33.86K
Market Cap
$29.45M
Enterprise Value-$28.55M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.16
Shares Outstanding5,041,932
10 Day Avg. Volume11,996
30 Day Avg. Volume33,863
Standard Deviation0.23
R-Squared0.02
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit71.73
Enterprise Value/Ebitda0.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
AlloVir News
PremiumCompany Announcements
AlloVir Appoints Vikas Sinha as New CEO
PremiumCompany Announcements
AlloVir and Kalaris Merge to Advance Retinal Therapies
PremiumCompany Announcements
AlloVir Finalizes $7 Million Lease Termination Deal
PremiumCompany Announcements
AlloVir Ends Lease Agreement with AMAG Pharmaceuticals
PremiumCompany Announcements
AlloVir Approves Executive Bonuses for Potential 2024 Buyout
---
Ownership Overview
Currently, No data available
---
ALVR FAQ
What was AlloVir’s price range in the past 12 months?
AlloVir lowest stock price was $7.96 and its highest was $24.15 in the past 12 months.
What is AlloVir’s market cap?
AlloVir’s market cap is $29.45M.
When is AlloVir’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AlloVir’s earnings last quarter?
AlloVir released its earnings results on Aug 01, 2024. The company reported -$0.05 earnings per share for the quarter, the consensus estimate of -$0.05 by $0.
Is AlloVir overvalued?
According to Wall Street analysts AlloVir’s price is currently Overvalued.
Does AlloVir pay dividends?
AlloVir does not currently pay dividends.
What is AlloVir’s EPS estimate?
AlloVir’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AlloVir have?
AlloVir has 5,041,932 shares outstanding.
What happened to AlloVir’s price movement after its last earnings report?
AlloVir reported an EPS of -$0.05 in its last earnings report, expectations of -$0.05. Following the earnings report the stock price went up 4.956%.
Which hedge fund is a major shareholder of AlloVir?
Currently, no hedge funds are holding shares in ALVR
---
AlloVir Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 112.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $9.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.55%
12-Months-Change
Fundamentals
Return on Equity
-63.33%
Trailing 12-Months
Asset Growth
-50.65%
Trailing 12-Months
Company Description
AlloVir
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.
---
ALVR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Sangamo Biosciences
―
Bluebird Bio
―
Fate Therapeutics
―
Iovance Biotherapeutics
―
Adaptimmune Therapeutics
―
Best Analysts Covering ALVR
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-37.15%
reiterated a sell rating 6 months ago
Copying Michael Ulz's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -37.15% per trade.
---